9:16 AM ET
8-K
Leadership Change
Carlsmed Leadership Change
Carlsmed appointed Richard Heppenstall as Chief Financial Officer, effective September 28, 2026, succeeding Leo Greenstein who departed the role. Mr. Greenstein will receive a $500,000 cash severance payment and accelerated equity vesting, while also serving as an advisor through the end of 2026. The company reaffirmed its full-year 2026 revenue guidance of $74 million to $78 million in conjunction with the transition.
- Counterparty
- Richard Heppenstall